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Background: Hepatic fatty acids (FAs) are modified through different metabolic pathways including elongation and
desaturation. These processes are catalyzed by elongases and desaturases, respectively. Glucose, by transcription
factors, regulates these processes. The aim of the study was to evaluate the influence of high carbohydrate diet
(68%) on the expression of elongase (Elovl-2, Elovl-5, and Elovl-6) and desaturase (Δ5D, Δ6D, Scd 1, Scd 2) genes
and the activity of the enzymes. The changes in serum lipid profile (triglycerides (TG), total cholesterol (TC), HDL
cholesterol) and glucose concentration were measured. Male Wistar rats were randomized into two study groups:
animals fed with high carbohydrate diet (n = 6; HiCHO) and a control group fed with a standard diet (n = 6; ST). The
expression of mRNA was determinate using reverse transcription PCR (RT-PCR). Hepatic FA composition was
determined by gas chromatography, and FA ratios were used to estimate the activity of enzymes. Serum lipid
profile and glucose concentration were measured using spectrophotometric methods.
Results: The mean values of transcript expression of all examined elongases and desaturases in liver HiCHO rats
were higher as compared to ST. Higher expression did not always correspond to higher activity (as index). More
monounsaturated FAs (MUFAs) were detected in the liver of HiCHO rats as compared to ST. Serum TG level was
higher in the HiCHO than in ST.
Conclusions: These studies support the notion that the regulation of both Elovl and desaturase expression may
play an important role in managing hepatic lipid composition in response to changes in dietary status.
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In mammals, the liver is responsible for the conversion
of excess dietary carbohydrates into triglycerides (TG),
through de novo lipogenesis (DNL). Fatty acids (FAs)
derived from a diet as well as synthesized from carbohy-
drates are modified through different metabolic path-
ways including elongation and desaturation [1]. FAs are
then used mainly for TG synthesis, then incorporated
into lipoproteins (mainly VLDL), and released to plasma* Correspondence: jagoda.drag@gmail.com
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(PL) and neutral lipids [5].
FA elongation is performed in four steps, catalyzed by
the following enzymes: ketoacyl-CoA synthase (elongase,
EC 2.3.1.), 3-ketoacyl-CoA reductase (KAR; EC 1.1.1.-),
3-hydroxyacyl-CoA dehydratase (EC 4.2.1.134), and 2,3-
transenoyl-CoA reductase (TER; EC 1.3.1.38). Elongation
occurs in the membrane of the endoplasmic reticulum
(ER) with malonyl-CoA as two-carbon donor, mitochon-
dria with acetyl-CoA as two-carbon donor and peroxi-
somes [2, 6–8]. Based on different substrate specificity,
elongases (Elovl) can be divided into four groups. The
first group are isoforms that elongates saturated (SFA)
and monounsaturated fatty acids (MUFA) (Elovl-1,
Elovl-3, Elovl-6, and Elovl-7); the second group includesle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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fatty acid (PUFA) synthesis; the third group is elongase 5
(Elovl-5) catalyzing elongation of 18–22 carbons of PUFA
as well as 16:1 n-7, and the last one is elongase 4 (Elovl-4)
that elongates saturated as well as unsaturated very long
chain FAs [4, 7–10].
FAs are also products in the oxidative desaturation
process. The introduction of a double bond into a carbon
chain occurs in the endoplasmic reticulum and requires
molecular oxygen, NAD(P)H, flavoprotein cytochrome b5
reductase, and the electron acceptor cytochrome b5 and is
catalyzed by a specific desaturase. In mammals, FA desa-
turases (EC 1.14.19) are acyl-CoA desaturases, which
include mainly Δ5 desaturase (Δ5D), Δ6 desaturase (Δ6D),
and Δ9 desaturase (Δ9D) (also known as stearoyl-CoA-
desaturase or SCD). Δ5D and Δ6D catalyze the biosyn-
thesis of PUFA. Their most common substrates are
C16–C24, mainly exogenous nutrients as α-linoleic acid
and linolenic acid. Δ9D catalyzes introduction of a
double bond into SFA with the preferred substrates as
C16:0-CoA and 18-CoA. Two isoforms of Δ9D called
Scd1 and Scd2 exist in rats [2, 5, 11, 12].
Physiological control of FA elongation and desaturation
remains poorly defined. It is known that the elongases and
desaturases appear to be mainly regulated on the tran-
scriptional level. It was proposed that transcriptional
factors such as carbohydrate-responsive element-binding
protein (ChREBP) [3, 13–17], liver X receptor α (LXRα)
[2, 18, 19], and sterol regulatory element-binding proteins
1c (SREBP-1c) [3, 8, 20–23] are key mediators in elon-
gases and desaturases messenger RNA (mRNA) levels
regulation. These transcription factors are modified by
different nutritional factors and metabolic states. It has
been shown that glucose as a substrate for FA synthesis
induces lipogenesis and expressions of lipogenic genes
[24]. In primary hepatocytes, Elovl-6 and SCD mRNAs
were induced by glucose [3]. Expression of the murine
liver stearoyl-CoA desaturase gene (SCD1) is induced
upon feeding fasted mice a fat-free, high carbohydrate
diet [25]. Expression and activity of elongases and desa-
turases was changed in adult male rats by HiCHO diet
supplemented with olive oil (10%, w/w), fish oil (10%,
w/w), or the PPAR-agonist WY14, 643 (0.1%, w/w) [1].
In the liver of diabetic rats (diabetes induced with
streptozotocin), declined Elovl-6 and SCD mRNA
abundance were shown [1]. Treatment of rat insuli-
noma (INS)-1 cells with elevated glucose increased de
novo FA synthesis by modification of elongases and
desaturases expression and enhanced production of
monounsaturated fatty acids [4].There are no studies
showing the changes of mRNA levels for many elon-
gases and desaturases together with their activities
(expressed as indexes) in Wistar’s rat livers after the
carbohydrate diet (68% sucrose).The aim of the present study was to evaluate the
influence of high carbohydrate diet (68%) on the ex-
pression of elongase (Elovl-2, Elovl-5, and Elovl-6) and
desaturases’ (Δ5D, Δ6D, Scd 1, and Scd 2) genes. The
activities of the Δ5D (20:4n-6/20:3n-6), Δ6D (18:3n-6/
18:2n-6), stearoyl-CoA desaturase 1 (SCD-1; 16:1n-7/
16:0, SCD-16 and 18:1n-9/18:0, SCD-18), DNL (16:0/
18:2n-6), Elovl-6 (18:0/16:0) and FA elongation (18:0 +
18:1 n-9/16:0) was expressed as FA ratios. For the first
time, the ratio 20:3 n-6/18:3 n-6 was used as the activ-
ity of Elovl-5 (Elovl-5 index). FA composition in rat
livers was determined. We have also measured the
changes in serum lipid profile (TG, total cholesterol
(TC), HDL cholesterol) and glucose concentration.
Methods
Animals
Animal experiments were conducted in accordance with
the guidelines for animal experiments of Animal Research
Committee and were approved by the Jagiellonian
University Ethic Committee.
Male Wistar rats weighing 151 ± 3 g were purchased
from the breeding facility of the Jagiellonian University
Faculty of Pharmacy. Animals were multi-caged and
maintained under standardized conditions of artificial
12-h light/dark cycle and constant room temperature
(21–23 °C). Animals were given ad libitum access to
food and water. Animals were randomized into two
study groups: (1) standard diet-fed controls (ST) (n = 6,
control) (Murigran, Concentrate and Mix Feed Factory
AGROPOL, Motycz) and (2) high-carbohydrate diet-fed
study group (HiCHO) (n = 6) (containing 68% carbohy-
drates, MP Biomedicals, 960236), until rats achieved
250 g (25 days ST vs. 21 days HiCHO). Then rats were
sacrificed, and liver tissues were excised and freeze-
clamped with aluminum tongs precooled in liquid nitro-
gen. From each rat, the blood was collected to obtain
serum, which was stored at −80 °C until analysis. All
samples were stored immediately at −80 °C and kept
frozen until further analysis.
Determination of elongases and desaturases mRNA
expression
Relative levels of specific mRNA for Elovl-2, Elovl-5, and
Elovl-6 and Δ5D, Δ6D, Scd 1, and Scd 2 in rat’s liver
were assessed by semi-quantitative reverse transcription
polymerase chain reaction (RT-PCR). Each gene was
amplified together with a housekeeping gene β-actin
(Actb; internal control). Total RNA was isolated from
the liver using TRI reagent (Sigma-Aldrich, Germany),
and complementary DNA (cDNA) was subsequently
synthesized using 1 μg total RNA, reverse-transcriptase,
and oligo dT primers (RevertAid™ H Minus First Strand
cDNA Synthesis Kit, Fermentas, Lithuania). cDNA was
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following manufacturer’s instructions. Each PCR reac-
tion was performed with 1.2 μl cDNA and 1.6 μl of spe-
cific primers for each gene (Table 1) that were designed
using Primer3 v.0.4.0 (Table 1). Mastercycler gradient EP
5331 (Eppendorf, Germany) was used. The PCR prod-
ucts were then subjected to agarose gel electrophoresis
(1.5% agarose gel), stained with ethidium bromide and
analyzed by densitometry using the Quantity One 4.2.1.
software (Bio Rad). Obtained data were calculated to the
mean value of the 200-bp band marker first (GeneRuler™
1 kb Plus DNA, Fermentas, Lithuania) and then normal-
ized to β-actin (in the same sample).
Lipid extraction and quantitation of hepatic FA
composition
Total lipid extraction from the liver was carried out
using a solution of chloroform/methanol (2:1) [26]. The
synthesis of FA methyl esters (FAME) was carried out
with 14% BF3 in methanol [27]. FAME were analyzed
using gas chromatography (Agilent 6890 N) with FID
and a DB-23 (60 m, 0.25 mm) column as described earl-
ier [28, 29]. Fatty acid methyl esters were identified
according to standards Supelco® 37 Component FAME
Mix (Sigma, Supelco). The data were analyzed using
ChemStation. Results were expressed in relative percent-
age of the sum of saturated (SAT), unsaturated (UNSAT),
monounsaturated (MUFA), and polyunsaturated fatty
acids (PUFA). The group of SAT includes 12:0, 14:0, 16:0,
17:0, 18:0, 21:0, and 22:0. The group of UNSAT includes
16:1 n-7, 18:1 n-9, 18:2 n-6, 18:3 n-6, 20:3 n-6, 20:4 n-6,
20:5 n-3, and 22:6 n-3. The group of MUFA includes 16:1
n-7 and 18:1 n-9. The group of PUFA includes 18:2 n-6,
18:3 n-6, 20:3 n-6, 20:4 n-6, 20:5 n-3, and 22:6 n-3.
Desaturation, elongation, and de novo lipogenesis
indexes
Particular FA ratios were used to estimate relative activ-
ities of the Δ5D (20:4n-6/20:3n-6), Δ6D (18:3n-6/18:2n-
6), stearoyl-CoA desaturase 1 (SCD-1; 16:1n-7/16:0,
SCD-16 and 18:1n-9/18:0, SCD-18), DNL (16:0/18:2n-6),Table 1 The primers sequences used for PCR
Gene name (symbol) Left primer sequence Right primer seq
Elovl-2 TCAACAATGGCAGCTCAAAG GGGGGATTTAC
Elovl-5 GAGGCATCCTGGTGGTGTAT ACGTGCAGGAC
Elovl-6 GCTACAACGGAGCAGAGGAC CCATTTTCAAGC
Δ5D GAAGGAACAGCAGTCCAAGC GTCTGGACTCGT
Δ6D ATCTGCCCTACAACCACCAG TGTGACCCACAC
Scd 1 CTGTTAGCCCAGCCTCACTC GTCTGCAGGAA
Scd 2 CCAGAGCGTACCAGCTTTTC GGCTGTCACCCA
β–actin (Actb) AGCCATGTACGTAGCCATCC CTCTCAGCTGTGElovl-6 (18:0/16:0), and FA elongation (18:0 + 18:1 n-9/
16:0) as described earlier [4, 30–32]. For the first time,
the ratio 20:3 n-6/18:3 n-6 was used as activity of Elovl-
5 (Elovl-5 index).
Determination of rat’s serum lipid profile and glucose
concentration
Serum lipid parameters including total cholesterol, HDL
cholesterol, triglycerides, and glucose concentration were
measured spectrophotometrically using standard kits
(AQUA-MED, Poland and BioMaxima, Poland). Tests
were performed according to manufacturer’s instructions.
Results were presented as mmol/L.
Statistics
Statistical calculations were performed using STATIS-
TICA 12.0 and GraphPad Prism v. 5.02. Shapiro-Wilk
test was used for normality assessing. Student’s t test for
unpaired samples (data are presented as mean ± SD) was
used to analyze mRNA expression for all elongases and
desaturases, with indicators such as PUFA and MUFA,
composed of 14:0, 16:0, 16:1 n-7, 17:0, 18:0, 18:1 n-9,
18:2 n-6, 18:3 n-6, 21:0, 22:0, 20:3 n-6, and 20:5 n-3, and
indexes for Δ5D, Scd 1 (C16), DNL, Elovl-5, Elovl-6,
elongation FAs, and glucose concentration and serum
lipid profile. Mann-Whitney U test (data are presented
as median and range) was used to analyze the indicators
SAT and UNSAT, composed of 12:0, 20:4 n-6, 22:6 n-3,
and indexes for Δ6D and Scd 1 (C18). Acceptable sig-
nificance level was set at p < 0.05.
Results
mRNA expression of elongases and desaturases
In the liver of HiCHO and ST rats, mRNA expression of
Elovl-2, Elovl-5, and Elovl-6 was obtained (Fig. 1). The
mean values of transcript expression of all examined elon-
gases in liver HiCHO rats were higher than in ST. In
HiCHO group, mRNA levels were increased for Elovl-2,
Elovl-5, and Elovl-6 by 1, 25, and 15% as compared to ST,
respectively. The difference in expression for Elovl-5 and
Elovl-6 were statistically significant (p < 0.05).uence Concentration; left/right primer Length of product
TTGGGAAAA 4 μm/4 μm 249
TGTGATCTG 4 μm/4 μm 247
CAACCAGT 4 μm/4 μm 247
GGAAGAGC 4 μm/4 μm 185
AAACCAGT 4 μm/4 μm 248
AACCTCTGC 2 μm/2 μm 668
ATCAGAAT 4 μm/4 μm 342
GTGGTGAA 4 μm/4 μm 228
Fig. 1 Relative levels of specific mRNA for Elovl-2, Elovl-5, and Elovl-6
in the liver of HiCHO and control groups. HiCHO high-carbohydrate
(68%) diet-fed study group (n = 6), ST rats standard diet-fed controls
(n = 6). Male Wistar rats weighing 151 ± 3 g were fed until achieved
250 g (21 days HiCHO vs. 25 days ST). The expression was determined
by RT-PCR. Each gene was amplified together with a housekeeping
gene β-actin (Actb; internal control). PCR products were separated on
1.5% agarose gel, stained with ethidium bromide, and analyzed by
densitometry using the Quantity One 4.2.1. software. Obtained data were
calculated to the mean value of the 200-bp band marker first and then
normalized to β-actin (in the same sample). Shapiro-Wilk test was used
for normality assessing. Student’s t test for unpaired samples; *p< 0.05
Fig. 2 Relative levels of specific mRNA for Δ5D, Δ6D, Scd 1, and Scd 2
in the liver of the HiCHO and control groups. HiCHO high-carbohydrate
(68%) diet-fed study group (n = 6); ST rats standard diet-fed controls
(n = 6). Male Wistar rats weighing 151 ± 3 g were fed until achieved
250 g (21 days HiCHO vs. 25 days ST). Each gene was amplified
together with a housekeeping gene β-actin (Actb; internal
control). The expression was determined by RT-PCR. *p < 0.05.
PCR products were separated on 1.5% agarose gel, stained with
ethidium bromide, and analyzed by densitometry using the Quantity
One 4.2.1. software. Obtained data were calculated to the mean value
of the 200-bp band marker first and then normalized to β-actin (in the
same sample). Shapiro-Wilk test was used for normality assessing.
Student’s t test for unpaired samples; *p < 0.05
Fig. 3 The mean values of indicators SAT, UNSAT, PUFA, and MUFA in
the liver of the HiCHO and control groups. HiCHO high-carbohydrate
(68%) diet-fed study group (n= 6); ST rats standard diet-fed controls
(n= 6). Male Wistar rats weighing 151 ± 3 g were fed until achieved
250 g (21 days HiCHO vs. 25 days ST). Fatty acid composition was
determined using gas chromatography. Results were expressed in
relative percentage of the sum of saturated (SAT), unsaturated (UNSAT),
monounsaturated (MUFA), and polyunsaturated fatty acids (PUFA). The
group of SAT includes 12:0, 14:0, 16:0, 17:0, 18:0, 21:0, and 22:0. The group
of UNSAT includes 16:1 n-7, 18:1 n-9, 18:2 n-6, 18:3 n-6, 20:3 n-6, 20:4 n-6,
20:5 n-3, and 22:6 n-3. The group of MUFA includes 16:1 n-7 and 18:1
n-9. The group of PUFA includes 18:2 n-6, 18:3 n-6, 20:3 n-6, 20:4 n-6,
20:5 n-3, and 22:6 n-3. Shapiro-Wilk test was used for normality assessing.
Student’s t test for unpaired samples (data are presented as mean ± SD)
was used to analyze indicators such as PUFA and MUFA; Mann-Whitney
U test (data are presented as median and range) was used to analyze
the indicators SAT and UNSAT. *p< 0.05
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of Δ5D, Δ6D, Scd 1, and Scd 2 desaturases was obtained
(Fig. 2). The mean values of transcript expression of all
examined desaturases in liver HiCHO rats were higher
than in ST. In HiCHO group, mRNA expression levels
increased by 5, 19, 69, and 16% as compared to ST for
desaturases Δ5D, Δ6D, Scd 1, and Scd 2, respectively.
The difference in expression for Δ6D, Scd1, and Scd2
desaturases was statistically significant (p < 0.05).
Hepatic fatty acid composition
The mean values of SAT, UNSAT, PUFA, and MUFA in
the liver of HiCHO and ST rats were calculated (Fig. 3).
In the liver of HiCHO rats, the value of SAT increased
by 4% and UNSAT decreased by 2.5% as compared to
ST group. In liver of HiCHO group, the mean value of
MUFA increased by 83% while the mean value of PUFA
decreased by 26% as compared to ST. The difference in
hepatic fatty acid composition for MUFA and PUFA
indicators were statistically significant (p < 0.05).
Fifteen fatty acids were determined using gas chroma-
tography. In the liver of HiCHO and ST rats, groupwise,
the relative percentage of individual fatty acids differed
(Fig. 4). The relative percentage of 12:0, 14:0, 16:0, 16:1 n-
7, 18:1 n-9, and 18:3 n-6 in rat liver of HiCHO group
increased by 4.5, 99, 32, 207, 71, and 203%, respectively, as
compared to ST. The relative percentage of 17:0, 18:0,
18:2 n-6, 22:0, 20:3 n-6, 20:4 n-6, 20:5 n-3, and 22:6 n-3
decreased by 51, 50, 3.8, 75, 50, 81%, 85.5, and 71%,
Fig. 4 The relative percentage of individual fatty acids in the liver of the HiCHO and control groups. HiCHO high-carbohydrate (68%) diet-fed study
group (n = 6); ST rats standard diet-fed controls (n = 6). Male Wistar rats weighing 151 ± 3 g were fed until achieved 250 g (21 days HiCHO vs. 25 days
ST). Fatty acid composition was determined using gas chromatography. Shapiro-Wilk test was used for normality assessing. Student’s t test for unpaired
samples (data are presented as mean ± SD) was used to analyze the composition of 14:0, 16:0, 16:1 n-7, 17:0, 18:0, 18:1 n-9, 18:2 n-6, 18:3 n-6, 21:0, 22:0,
20:3 n-6, and 20:5 n-3, and Mann-Whitney U test (data are presented as median and range) was used to analyze the composition of 12:0, 20:4 n-6, and
22:6 n-3; *p < 0.05
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(21:0) was detected only in the liver of HiCHO group not
in ST group. The difference in the relative percentage of
individual fatty acids for 16:0, 16:1 n-7, 18:0, 18:1 n-9, 18:3
n-6, 21:0, 22:0, 20:3 n-6, 20:4 n-6, 20:5 n-3, and 22:6 n-3
was statistically significant (p < 0.05).
Desaturation, elongation, and DNL indexes
In the rat’s liver, the differences in the value of indexes
for desaturation, elongation, and DNL were observed
(Table 2). In HiCHO group, indexes for Δ5D, Elovl-5,
Elovl-6, and FA elongation decreased by 80, 84, 62, and
17%, respectively, as compared to ST group. In HiCHO
group, indexes for Δ6D, SCD1(16), SCD1(18), and DNL
increased by 153, 137, 311, and 27% as compared to ST
group. The differences in the indexes for Δ5D, Δ6D,
SCD1 (16), SCD1 (18), Elovl-5, and Elovl-6 were statisti-
cally significant (p < 0.05).Table 2 The mean values of indexes for desaturation,
elongation, and DNL. Data are presented as mean ± SD or
median (range)
Name Index ST HiCHO
Δ5D 20:4 n-6/20:3 n-6 0.25 ± 0.11 0.05 ± 0.06*
Δ6D 18:3 n-6/18:2 n-6 0.07 (0.02–0.07) 0.17 (0.14–0.19)*
Scd 1 (C16) 16:1 n-7/ 16:0 0.07 ± 0.02 0.17 ± 0.02*
Scd 1 (C18) 18:1 n-9/18:0 0.92 (0.71–2.56) 3.79 (3.13–4.34)*
DNL 16:0/18:2 n-6 1.02 ± 0.36 1.29 ± 0.22
Elovl-5 20:3 n-6/18:3 n-6 9.27 ± 1.98 1.49 ± 0.43*
Elovl-6 18:0/16:0 0.60 ± 0.16 0.23 ± 0.02*
Elongation FA 18:0 + 18:1 n-9/16:0 1.3 ± 0.1 1.07 ± 0.06*
*p < 0.05Analysis of serum lipid profile and glucose concentration
Parameters of serum lipid profile and glucose concen-
tration differed in two study groups (Fig. 5). In
HiCHO group, glucose, TG, TC, and HDL cholesterol
increased by 11, 241, 23, and 7.4%, respectively, as
compared to ST. Significantly higher concentration
was only for TG (p < 0.05).Fig. 5 The mean concentrations of glucose, TG, TC, and HDL
cholesterol in the serum of the HiCHO and control groups. HiCHO
high-carbohydrate (68%) diet-fed study group (n = 6); ST rats standard
diet-fed controls (n = 6). Male Wistar rats weighing 151 ± 3 g were fed
until achieved 250 g (21 days HiCHO vs. 25 days ST). Shapiro-Wilk test
was used for normality assessing. Student’s t test for unpaired samples
(data are presented as mean ± SD) was used to analyze glucose
concentration and serum lipid profile. *p < 0.05. Results are expressed
as millimolar per liter
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De novo FA synthesis and MUFA
Diets enriched in carbohydrates are well established to
alter FA metabolism and increase TG accumulation
[4]. In our study, we observed the active DNL and the
influence of the HiCHO diet on increased expression
of all studied enzymes resulting in increased produc-
tion of MUFAs. The most important changes concern
metabolism of 16:0 and 18:0 as a dominant products of
DNL [30]. Both FAs are subjects to elongation or de-
saturation processes [33]. On the basis of our observa-
tion, the desaturation is a main process of 16:0 and
18:0 metabolism in liver of rat fed HiCHO diet because
of a higher expression of mRNA for Scd1 (Fig. 2), a
higher content of 16:1 n-7 and 18:1 n −9 (Fig. 4), and a
higher activity of desaturases as indexes for Scd1 (C16)
and Scd1 (C18) (Tab. 2) as compared to control group.
The index for Scd1 (C16) is proposed as an indirect
biomarker of DNL [30]. Scd 1 is the main isoform in
MUFAs synthesis with 16:0 and 18:0 as main sub-
strates [34]. As Scd1 plays a crucial role in this synthe-
sis, the role of Scd2 remains unclear. Our findings
indicate that 16:0 and 18:0 metabolism is directed to
MUFAs synthesis as 16:1 n-7 and 18:1 n-9, respect-
ively, that are main components of TG and PL. Espe-
cially, 18:1 n-9 is the preferred substrate for TG
storage of excess FAs [4]. In our study, it was observed
that in HiCHO group, liver tissues contain statistically
more MUFAs (with prevalence 16:1 n-7 and 18:1 n-9
fatty acids; Figs. 3 and 4) and less PUFAs than control.
The study by Wang et al. [1] indicates that 16:0, 18:0,
18:1 n-9, and 18:2 n-6 acids represent the major fatty
acids and 16:1 n-7 is an end product of DNL and Scd.
The results from our study (Fig. 4) are consistent with
the results obtained by Wang et al. [1]. The last but
not the least, in our study, serum level of TG was
higher in HiCHO than in control (Fig. 5) that may
indicate that newly synthesized FAs as TG incorpo-
rated into lipoproteins were released to plasma.
The glucose is converted into FAs in DNL process by
the induction of genes transcription that increase glucose
metabolism and lipogenesis in the liver [4]. According to
substrate specific, Elovl-6, Scd1, and Scd2 desaturases
might be responsible for these changes [2, 8]. Genes of
Elovl-6, Scd1, and Scd2 desaturases contain the response
element for transcriptional factors such as SREBP, LXR,
and ChREBP, in their promoter [1]. Wang et al. [1]
indicate that in primary hepatocytes glucose regulates
both Elovl-6 and Scd expression by mechanisms that
control the nuclear abundance of ChREBP and MLX.
It is known that during carbohydrates excess, glucose/
insulin stimulates hepatic lipogenesis via LXR and
SREBP-1 [18, 35, 36]. Glucose as natural ligand for
LXR may induce FA and TG synthesis as it was seenin our study, where rat fed with HiCHO diet had
higher serum TG level than control group. ChREBP, a
central transcriptional regulator of hepatic DNL, is
also regulated by glucose itself, increasing expression
of mRNA for elongase 6 and Scd desaturases [1, 2].
PUFA synthesis
Metabolism of PUFAs depends on the content of 18:2 n-
6 and 18:3 n-3 as essential FAs derived from a diet.
These FAs are substrates for elongases and desaturases.
In our study, we observed that liver tissues of HiCHO
group contain statistically less PUFAs than control group
(Fig. 3). In the current study, it was observed that the
diet enriched in glucose increased expression of Elovl-5,
Δ5D, and Δ6D mRNA (Figs. 1 and 2) but relative activ-
ities of these enzymes were different (Tab. 2). The result
of these processes is reduction of PUFA synthesis. Be-
cause of the low activity of Elovl-5 and Δ5D, we ob-
served the lower content of 20:3 n-6, 20:4 n-6, and 22:6
n-3 PUFAs in HiCHO group than in control group. The
control mechanism of decreasing activity of these two
enzymes remains unresolved. Moon et al. [10] reported
that ablation of Elovl5 increases hepatic lipid content, at
least in part by inducing SREBP-1, a key transcription
factor controlling de novo lipogenesis. Tissues of
Elovl5(−/−) mice accumulated the C18 substrates of
ELOVL5 and the levels of C20:4 n-6 and C22:6 n-3 were
decreased [10]. The same changes in the content of FAs
were observed in our study but mainly as a result of
lower relative activity of Elovl-5 than the lower level of
expression. It cannot be excluded that high expression
of SREBP-1c decrease activity of Elovl-5. It may explain
the results achieved in the current study because of glu-
cose as a strong inducer of SREBP-1. Recently, Wang
et al. [37] reported the metabolic effects of adenoviral-
mediated overexpression of Elovl-5. The relative levels
of 20:4 n-6 and 22:6 n-3 in mouse livers that overex-
pressed Elovl-5 were decreased despite an increase in
20:3 n-6. Thus, it is possible that the Δ5 desaturase be-
comes rate-limiting in case of Elovl-5 overexpression
[37]. Δ5D a rate-limiting enzyme, as it was suggested by
Wang, can explain only low levels for 20:4 n-6 and 22:6
n-3. More research is needed to clarify the cause of
Elovl-5 and Δ5D low activity.
In the current study, only two members of n-3 PUFA
family were determined (20:5 n-3 and 22:6 n-3; Fig. 4). It
is difficult to explain changes in content of these FAs in
the liver because of the lack of 18:3 n-3 precursor. We
may conclude that the hypothesis stated by Wang [37]
(Δ5 desaturase is a rate-limiting enzyme) may explain
lower hepatic levels of 20:5 n-3 and 22:6 n-3 in HiCHO
group compares to ST.
The expressions of Elovl-5, Δ5D, and Δ6D involved in
PUFA metabolism are under control of transcription
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38]. Genes of Elovl-5, Δ5D, and Δ6D contain the re-
sponse element for these transcriptional factors in their
promoter. Only elongase 2 is not regulated in this way.
In our study, expression of elongase 2 did not change in
liver of rats fed high carbohydrate diet in comparison to
control group. Our results complements data obtained
by Wang et al. [3], who investigated the influence of dif-
ferent diets (high carbohydrate diet supplemented with
olive oil, fish oil, or olive oil plus WY14,643) on mRNA
expression for elongase 2. None of them changed the
mRNA expression of elongase 2 [3]. Hepatic Elovl-5 is
regulated by LXRα-SREBP-1c [19]. Mitro et al. [18]
showed that glucose binds and stimulates the transcrip-
tional activity of LXR. These findings may suggest the
regulation of Elovl-5 expression by these factors in liver
of rats fed high carbohydrate diet. The problem of low
activity of Elovl-5 remains unresolved. Wang et al. [1]
suggest that the induction of Δ5D and Δ6D by insulin
and T1317 (the LXR agonist) is attributable to increased
SREBP-1 nuclear abundance. These findings, altogether,
may explain higher expression of Δ5D and Δ6D in livers
of rats of HiCHO group as compared to control group.
PPAR-α expressed primarily in the liver is essential for
metabolic adaptation to starvation by inducing genes for
β-oxidation and ketogenesis and by downregulating en-
ergy expenditure [39]. It can confirm that this transcrip-
tional factor through a high carbohydrate diet given ad
libitum plays a minor role in regulation of lipogenic gene
transcription. To sum up, increased hepatic glucose flux
activates SREBP and LXR, which act to couple increased
carbohydrate intake with induction of lipogenic genes as
Δ5D and Δ6D.
Conclusions
In this study, we have established that hepatic fatty acid
elongases (Elovl-5 and Elovl-6) and desaturases (Δ5D,
Δ6D, Scd-1, and Scd-2) are regulated by high carbohy-
drate diet. Additionally, we have indicated that changes
in activity do not always correspond to changes of Elovl
and desaturases mRNA levels. We have demonstrated
that elevated intake of glucose modified FAs compos-
ition in liver with prevalence of MUFA as well as in-
creased serum level of TG, of which MUFA are main
components. The changes might be connected with un-
favorable lipogenesis in liver. These studies support the
notion that the regulation of both Elovl and desaturase
expression may play an important role in managing hep-
atic lipid composition in response to changes in dietary
status.
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